Real-World Evidence: A Primer
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Real-world evidence (RWE) is clinical evidence on a medical product’s safety and efficacy that is generated using real-world data (RWD) resulting from routine healthcare delivery. There are several sources of RWD, including electronic health records (EHRs), registries, claims/billing data, and patient-generated data, as well as those from mobile health applications and wearable devices. Real-world data from these sources can be collected and analysed through different study designs such as prospective and retrospective cohort studies, case–control studies, and pragmatic clinical trials. Real-world evidence in the form of post-marketing surveillance has been extensively used to generate pharmacovigilance data. Of late, it has been realised that, apart from safety, RWE has additional applications in different stages of the drug approval cycle, and can be used to optimize the design of randomised controlled trials (RCTs). There has been an increasing awareness and acceptance of RWE from different stakeholders, including physicians, pharmaceutical companies, payers, regulators, and patients. Several regulatory authorities have also created frameworks and guidelines for efficient harnessing of RWE while acknowledging several challenges in RWD collection and analysis. The purpose of this review is to offer an outline of the current information on RWE, its advantages and disadvantages, as well as the associated challenges and ways to overcome them, while also throwing some light on the future of RWE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scalable and accurate deep learning with electronic health records
Rajkomar, A., Oren, E., Chen, K., Dai, A. M., Hajaj, N., Hardt, M., Liu, P. J., Liu, X., Marcus, J., Sun, M., et al. (2018) · npj Digital Medicine · doi:10.1038/s41746-018-0029-1 · Cited by 2,648 · cited 1×
“One study even reported successful prediction of multiple medical events when ML tools were applied to EHR data from various centres [85].”
MethodFord, I., & Norrie, J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510059 · Cited by 1,405 · cited 3×
“Often, some prospective, multicentre, observational studies are conducted as part of routine clinical practice, and such trials are called pragmatic clinical trials [33].”
BackgroundA pragmatic view on pragmatic trials
Patsopoulos, N. A. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.2/npatsopoulos · Cited by 844
Machine learning and wearable devices of the future
Beniczky, S., Karoly, P., Nurse, E., Ryvlin, P., & Cook, M. (2021) · Epilepsia · doi:10.1111/epi.16555 · Cited by 155
Cited by
Decentralisation in Clinical Trials and Patient Centricity: Benefits and Challenges
Sinha, S. D., Chary Sriramadasu, S., Raphael, R., & Roy, S. (2024) · Pharmaceutical Medicine · doi:10.1007/s40290-024-00518-x · Cited by 26
Data Quality–Driven Improvement in Health Care: Systematic Literature Review
Lighterness, A., Adcock, M., Scanlon, L. A., & Price, G. (2024) · Journal of Medical Internet Research · doi:10.2196/57615 · Cited by 26
“The uniqueness dimension identifies where duplication of objects, events, or values are not expected [10,26].”
Influential
Metadata
- Authors
- Dang, A.
- Venue
- Pharmaceutical Medicine
- Published
- 2023-01
- Volume
- 37
- Issue
- 1
- Pages
- 25-36
- ISSN
- 0265-0673 (ISSN-L)
- 1178-2595
- 1179-1993
- OpenAlex
- W4313538727
- Cited by
- 241
- References
- 4
- FWCI
- 49.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Real-World Evidence: A Primer. https://app.cochat.ai/papers/10.1007/s40290-022-00456-6
- The paper
- Dang, A. (2023). Real-World Evidence: A Primer. Pharmaceutical Medicine. https://doi.org/10.1007/s40290-022-00456-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.